Improving resectability and survival in patients with primary duodenal carcinoma

American Journal of Surgery
R DelcoreA S Hermreck

Abstract

Of 35 patients with primary duodenal carcinoma (PDC), 13 were treated between 1960 and 1974 (group I) and 22 between 1975 and 1990 (group II). PDCs were found in the first 5 portions of the duodenum (14%), second 18 (51%), third 8 (23%), and fourth 4 (12%). Five patients (38%) in group I were deemed to have unresectable disease compared with only one patient (5%) in group II. Eight patients (62%) in group I underwent resection by either pancreatoduodenectomy (4) or segmental resection (4), and 20 patients (95%) in group II had pancreatoduodenectomy (17) or segmental resection (3). Operative mortality was 31% in group I and 0% in group II. Mean survival was 7 months (range: 0 to 22 months) in group I and 48 months (range: 6 to 218 months) in group II. None of the patients in group I survived for 2 years, whereas the 5-year survival for patients in group II was 62%. This experience suggests that resectability, operative mortality, and survival in patients with PDCs have improved markedly in recent years.

References

Aug 1, 1992·AJR. American Journal of Roentgenology·E A KazerooniI R Francis
Oct 1, 1988·World Journal of Surgery·E C LaiR K Tompkins
Dec 1, 1989·American Journal of Surgery·R DelcoreA S Hermreck
Mar 12, 1973·JAMA : the Journal of the American Medical Association·P L SchnurE G Harrison
Feb 1, 1981·American Journal of Surgery·D R JoestingL H Weiland

❮ Previous
Next ❯

Citations

Jan 1, 1995·Surgery Today·S YildirimN Ozdemir
Aug 1, 1995·Journal of Gastroenterology·T SatoT Matsushiro
Feb 22, 2012·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Edwin O OnkendiFlorencia G Que
Apr 29, 2009·Journal of Gastrointestinal Cancer·Shao-Liang HanSheng-Hong Lan
May 1, 2010·Journal of Gastrointestinal Cancer·Shao-Liang HanSheng-Hong Lan
Jul 14, 2001·ANZ Journal of Surgery·R R HutchinsS J Snooks
Jan 1, 2012·Journal of Surgical Case Reports·D LamR Hernandez-Alejandro
Jan 23, 1999·Journal of Clinical Gastroenterology·Y TanakaY Esaki
Jun 11, 2011·American Journal of Clinical Oncology·Kyubo KimSung W Ha
Jun 1, 1995·Postgraduate Medical Journal·O A AdedejiM Garcia-Zarco
Feb 2, 2008·World Journal of Surgical Oncology·Kongkrit ChaiyasateVijay K Mittal
Dec 15, 2011·Annals of Surgical Oncology·George A PoultsidesRichard D Schulick
Jun 14, 2000·AJR. American Journal of Roentgenology·D BradfordE Einhorn
Oct 27, 2011·International Surgery·Hiroshi KawahiraHisahiro Matsubara
Aug 28, 2014·Annals of Surgical Oncology·Jordan M CloydGeorge A Poultsides
Aug 1, 2008·World Journal of Surgery·Hyung Geun LeeDong Wook Choi
Mar 29, 2000·American Journal of Surgery·I G KaklamanosA S Livingstone
Nov 10, 2009·ANZ Journal of Surgery·Joseph GeorgeSundar Elangovan
May 10, 2013·ANZ Journal of Surgery·Sang Yeup LeeYoung-Joo Lee
May 28, 2013·International Journal of Surgery Case Reports·Toru NakanoNoriaki Ohuchi
Mar 30, 2016·World Journal of Gastrointestinal Surgery·Jordan M CloydBrendan C Visser
Feb 22, 2012·World Journal of Gastrointestinal Surgery·Federico SistaGianfranco Amicucci
Aug 27, 2015·World Journal of Gastroenterology : WJG·Feliciano Chanana PaquissiFrancisco Viamontes Diaz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.